0001209191-20-063915.txt : 20201216
0001209191-20-063915.hdr.sgml : 20201216
20201216194613
ACCESSION NUMBER: 0001209191-20-063915
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201214
FILED AS OF DATE: 20201216
DATE AS OF CHANGE: 20201216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kwan Pui San
CENTRAL INDEX KEY: 0001733642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 201393865
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-14
0
0001340652
ChemoCentryx, Inc.
CCXI
0001733642
Kwan Pui San
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
0
1
0
0
Principal Acctg Officer
Common Stock
2020-12-14
4
M
0
834
3.57
A
4066
D
Common Stock
2020-12-14
4
M
0
6667
6.62
A
10733
D
Common Stock
2020-12-14
4
M
0
1456
11.02
A
12189
D
Common Stock
2020-12-14
4
S
0
8957
65.0215
D
3232
D
Common Stock
2020-12-15
4
M
0
3333
6.62
A
6565
D
Common Stock
2020-12-15
4
M
0
10919
11.02
A
17484
D
Common Stock
2020-12-15
4
M
0
16675
10.86
A
34159
D
Common Stock
2020-12-15
4
M
0
11666
9.04
A
45825
D
Common Stock
2020-12-15
4
S
0
42593
65.0632
D
3232
D
Stock Option (right to buy)
3.57
2020-12-14
4
M
0
834
D
2026-03-07
Common Stock
834
0
D
Stock Option (right to buy)
6.62
2020-12-14
4
M
0
6667
D
2027-02-28
Common Stock
6667
4167
D
Stock Option (right to buy)
6.62
2020-12-15
4
M
0
3333
D
2027-02-28
Common Stock
3333
834
D
Stock Option (right to buy)
10.86
2020-12-15
4
M
0
16675
D
2028-03-05
Common Stock
16675
18066
D
Stock Option (right to buy)
11.02
2020-12-14
4
M
0
1456
D
2029-03-04
Common Stock
1456
39044
D
Stock Option (right to buy)
11.02
2020-12-15
4
M
0
10919
D
2029-03-04
Common Stock
10919
28125
D
Stock Option (right to buy)
9.04
2020-12-15
4
M
0
11666
D
2029-11-01
Common Stock
11666
28334
D
Includes 2,739 shares acquired under the Issuer's employee stock purchase plan since the last date of the reporting person's last ownership report.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $65.00 to $65.18 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $65.00 to $65.40 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
As of December 14, 2020, and prior to this transaction, the exercised options were fully vested.
Not applicable.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2020-12-16